Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: A multicenter follow-up study

Diabetes Technology and Therapeutics

Volumn 10, Issue 1, 2008, Pages 25-38

  Cefalu, William T ^a   Mathieu, Chantal ^b   Davidson, Jaime ^c   Freemantle, Nick ^d   Gough, Stephen ^e   Canovatchel, William ^f  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIABETES CONTROL; DIET THERAPY; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONLINE SYSTEM; PATIENT DECISION MAKING; PATIENT SELECTION; PERCEPTION; PHYSICIAN; PRIORITY JOURNAL;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PATIENTS;

EID: 38349000826     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0249     Document Type: Article

References (19)

1. Koopmanschap M; CODE-2 Advisory Board: Coping with type II diabetes: the patient's perspective. Diabetologia 2002;46:302-303.
2. Jonsson B; CODE-2 Advisory Board: Revealing the cost of Type II diabetes in Europe. Diabetologia 2002;45(Suppl):S5-S12.
3. Liebl A, Mata M, Eschwege E: Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 2002;45(Suppl):S23-S28.
4. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes. Diabetes Care 2004;27:17-20.
5. Fox KM, Gerber RA, Bolinder, B, Chen J, Kumar S: Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006;28:388-395.
6. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM: Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-474.
7. Hunt LM, Valenzuela MA, Pugh JA: NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 1997;20:292-298.
8. Peyrot M, Rubin RR, Lauritzen T, Skovlund S, Snoek FJ, Mathews DR, Landgraf R, Kleinebreil L; International DAWN Advisory Panel: Resistance to insulin therapy among patients and providers. Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-2679.
9. Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P: Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007;24:1412-1418.
10. Calvert MJ, McManus RJ, Freemantle N: Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract 2007;57:455-460.
11. Nichols G, Koo Y, Menditto L: Delay in treatment escalation when glycemic control is not maintained on oral combination therapy [abstract 535-P]. Diabetes 2006;55(Suppl 1):A127.
12. Harris MA, Lustman PJ: The psychologist in diabetes care. Clin Diabetes 1998;16:1-7.
13. Norris SL, Engelgau MM, Venkat Narayan KM: Effectiveness of self-management training in type 2 diabetes. Diabetes Care 2001;24:561-587.
14. Korytkowski M: When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002;26(Suppl 3):S18-S24.
15. National Institutes of Health, National Heart Lung and Blood Institute: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Publication No. 98-4083. Bethesda, MD: National Institutes of Health, 1998.
16. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-343.
17. Heinemann L: Overcoming obstacles: new management options. Eur J Endocrinol 2004;151(Suppl 2):T23-T27.
18. Zambanini A, Newson RB, Maisey M, Feher MD: Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46:239-246.
19. Hauber AB, Johnson FR, Sauriol L, Lescrauwaet B: Risking health to avoid injections. Diabetes Care 2005;28:2243-2245.